Cadre (CDRE) Q2 2026 earnings review
Massive Top-Line Beat Driven by M&A, But Quality of Earnings is Under Pressure
Cadre delivered a powerful Q2 top-line beat, printing $207.1M in revenue (+32% YoY) against prior guidance of ~$178M. The robust performance was fueled by 5% organic growth, a normalization in the Distribution segment, and strong contributions from recent acquisitions (TYR Tactical, Alien Gear). Management subsequently raised FY26 net sales and Adjusted EBITDA guidance. However, investors must look beneath the adjusted metrics: GAAP Net Income actually fell 7% YoY to $11.4M due to adverse FX, contingent consideration expenses, and inventory step-up amortization. While the record $368M backlog provides excellent visibility, the growing chasm between 'adjusted' profitability and actual bottom-line cash generation warrants close monitoring.
🐂 Bull Case
The orders backlog hit a second consecutive record of $368M, up sequentially despite heavy Q2 deliveries. Coupled with massive new long-term defense and FBI IDIQ contract wins, revenue is heavily de-risked into 2027.
Alien Gear and TYR Tactical are actively padding the top line, while the 'Cadre operating model' successfully drove Q2 Adjusted EBITDA margins up 310 bps YoY to a highly lucrative 20.3%.
🐻 Bear Case
Management celebrates profitability, but GAAP Net Income is Reversing. The company added back over $13M in Q2 alone for FX losses, contingent M&A payouts, and inventory adjustments. True bottom-line conversion is stalling.
Aggressive capital deployment ($400M+ since Jan 2024) pushed net debt to $320.3M. Net Debt/Adj EBITDA has climbed to 2.5x, narrowing the buffer before hitting management's internal ~3.0x ceiling.
⚖️ Verdict: ⚪
Neutral/Bullish. The operational execution on integrating acquisitions and winning government contracts is stellar. However, the aggressive M&A spree is muddying the true earnings profile, and debt is mounting. We prefer to see sustained organic cash flow conversion before becoming outright bullish.
Key Themes
M&A Engine Powering the Top Line
Cadre has deployed $455M in capital since 2022, acquiring seven businesses including TYR Tactical and Alien Gear Holsters. This strategy is Accelerating growth, directly responsible for the massive 32% YoY revenue spike in Q2. Management continues to evaluate a robust pipeline of 'asset-light, high ROIC' targets, cementing acquisitions as the primary volume driver over organic growth.
Major Government IDIQ Wins Boost Defense Profile
The company's technology is gaining traction in elite government tiers. Safariland was recently selected as the ballistic panel provider for Predictive Ballistics' Overt Armor Kit (OAK), which just won a five-year, $61M IDIQ contract with the FBI. Concurrently, Cadre secured a second PO ($8.4M) for the military's BEMO blast sensor program, bringing total received funding to $18.4M. This validates product innovation and locks in future volume.
Nuclear Tailwinds Gaining Velocity
The macro narrative for the Nuclear division is Accelerating. Management cited an $8.2B FY2027 DOE request for clean-up initiatives and a U.S. roadmap to triple nuclear capacity by 2050 (adding ~200 GW). The nuclear backlog increased $13M YTD. This shifts the segment from a specialized niche to a primary structural growth pillar.
GAAP to Non-GAAP Divergence
A critical red flag contradicts management's 'strong profitability' narrative: Net Income dropped 7% YoY to $11.4M despite sales jumping 32%. The gap is bridged by heavy add-backs, notably $5.87M in contingent consideration for prior deals and $4.92M in inventory step-up amortization over the past six months. The heavy reliance on Adjusted EBITDA (which surged 56%) obscures the real cash drag of Cadre's M&A spree.
Leverage Creep Restricting Flexibility
The balance sheet is absorbing the weight of the M&A strategy. Net debt (total debt minus cash) spiked to $320.3M at the end of Q2, up drastically from $184.4M at year-end 2025. While Total Debt / Adj. EBITDA sits at 3.0x (2.5x net), this is nearing the upper bounds of historical comfort levels. Interest expense is Accelerating, hitting $5.0M in Q2 (up from $3.6M a year ago), eating directly into cash flow.
Distribution Segment Resiliency Uncertain
After flagging softness in discretionary third-party distribution in Q1, management noted a return to 'more normalized demand' in Q2. However, Distribution gross margins compressed to 22.8% from 23.1% YoY, and H1 margins are down 90 bps. Given local government budget constraints, this segment remains vulnerable and Stable at best, lacking the momentum of the core Product segment.
Other KPIs
Accelerating. Backlog increased by $13 million sequentially in Q2, marking the second consecutive quarterly record. The growth was driven heavily by EOD demand, specifically sensors and robots, providing a massive buffer for H2 2026 execution.
Accelerating. An excellent result, up from 41.7% in Q2 2025 and an improvement sequentially from Q1. This was driven by favorable pricing, strong duty gear mix, and higher-margin Zircaloy product sales, successfully overcoming the negative drag of inventory step-up amortization.
Guidance
Accelerating. Management raised the full-year outlook from the prior range of $736M - $758M. The new midpoint ($759M) implies robust 24.4% YoY growth over FY 2025. The raise accounts for TYR Tactical (~$100M), Alien Gear (~$11M), and roughly 5% organic growth.
Accelerating. Raised from the previous range of $136M - $141M. The midpoint ($141.5M) implies ~26.7% YoY growth and confirms management's expectation for significant operating leverage and margin expansion in the back half of the year as large, high-margin orders ship.
Stable. Unchanged from prior guidance, representing a minor step-up from previous years to accommodate capacity expansion, primarily in the nuclear businesses.
Key Questions
M&A Contingent Considerations
With $5.87 million recorded in contingent consideration remeasurements this year impacting Net Income, what is the maximum remaining exposure for earn-outs related to TYR and ICOR, and when will this cash impact peak?
Leverage Thresholds
Net debt to LTM Adjusted EBITDA is now 2.5x. Given the stated goal of staying opportunistic in M&A, are you willing to pierce the 3.0x threshold, or will you pause acquisitions to de-lever organically over the next 12 months?
Organic Top-line Durability
You cited 5% organic growth in Q2. As the massive TYR and Alien Gear acquisitions lap their one-year marks in early 2027, what is your normalized expectation for organic growth across the core safety and nuclear segments without the benefit of acquired backlog?
Distribution Segment Viability
While Distribution recovered to 'normal' demand levels this quarter, the gross margins remain structurally lower (~22%) and vulnerable to municipal budget cuts. Does owning this third-party distribution channel remain a core strategic priority long-term?